| FET PET radiomics for differentiating pseudoprogression from early tumor progression in glioma patients post-chemoradiation P Lohmann, MA Elahmadawy, R Gutsche, JM Werner, EK Bauer, ... Cancers 12 (12), 3835, 2020 | 90 | 2020 |
| Predictive value of FDG PET/CT versus bone marrow biopsy in pediatric lymphoma S Badr, M Kotb, MA Elahmadawy, H Moustafa Clinical nuclear medicine 43 (12), e428-e438, 2018 | 29 | 2018 |
| Diagnostic value of F-18 FDG PET/CT for local and distant disease relapse surveillance in surgically treated RCC patients: Can it aid in establishing consensus follow up strategy? MA Elahmadawy, MSS Elazab, S Ahmed, M Salama Nuclear Medicine Review 21 (2), 85-91, 2018 | 18 | 2018 |
| FET PET radiomics for differentiating pseudoprogression from early tumor progression in glioma patients post-chemoradiation. Cancers (Basel). 2020; 12 P Lohmann, MA Elahmadawy, R Gutsche, JM Werner, EK Bauer, ... DOI: https://doi. org/10.3390/cancers12123835, 0 | 13 | |
| Survival outcome of intermediate risk neuroblastoma at Children Cancer Hospital Egypt. MF Hossam Elzomor , Gehad Ahmed , Salma Elmenawi , Naglaa Elkinaai ... J Egypt Natl Canc Inst. 30 (1), 21-26, 2018 | 9* | 2018 |
| Watch and see strategy in selected neuroblastoma case scenarios: success and limitations M Fawzy, H El Zomor, S El Menawi, N Elkinaai, G Ahmed, A Refaat, ... Journal of Pediatric Hematology/Oncology 41 (6), e384-e387, 2019 | 7 | 2019 |
| Diagnosis of pseudoprogression using FET PET radiomics. NG P Lohmann, M A Elahmadawy, J Werner, M Rapp, G Ceccon, G R Fink, N J Shah ... Neuro-Oncology 21 (3), iii19, 2019 | 5* | 2019 |
| Prediction of pathological response using 18F FDG PET/CT derived metabolic parameters in locally advanced breast cancer patients MAE Salwa Abd El-Gaid , Marwa Nabil AbdelHafez, Ghada Mohamed, Mohamed Samy ... Nucl Med Commun ., 2021 | 4* | 2021 |
| Theranostics and molecular imaging training in the arab world: present and prospects ME Juweid, S Al-Qasem, M Haidar, NE Ghawi, N Al-Bulushi, M Zein, ... European Journal of Nuclear Medicine and Molecular Imaging 51 (12), 3491-3495, 2024 | 2 | 2024 |
| Prognostic value of initial [18F] FDG PET/computed tomography volumetric and texture analysis-based parameters in patients with head and neck squamous cell carcinoma MA Elahmadawy, A Ashraf, H Moustafa, M Kotb, S Abd El-Gaid Nuclear Medicine Communications 44 (7), 653-662, 2023 | 2 | 2023 |
| Value of diffusion MRI versus [18F] FDG PET/CT in detection of cervical nodal metastases in differentiated thyroid cancer patients AM Shalash, MA Elahmadawy, SY Heikal, AA Amin, AA Youssef Nuclear Medicine Review 25 (2), 112-118, 2022 | 2 | 2022 |
| F18 FET PET/CT in Brain Tumors. MA Abdelwahab, O W. Egyptian J. Nucl. Med. 13 (1), 1-6, 2016 | 2 | 2016 |
| Prognostic value of FDG-PET/CT in pediatric neuroblastoma M Abdelwahab, W Omar, H Mostafa, M Kotb, S Abd El-Gaid, M Fawzy Journal of Nuclear Medicine 57 (supplement 2), 1507-1507, 2016 | 2 | 2016 |
| Predictive value of FDG PET/CT in pediatric Neuroblastoma patients M Amr, W Omar, H Moustafa, M Kotb, S Abd El-Gaid, M and Fawzy Egyptian J. Nucl. Med. 10 (2), 46-59, 2014 | 2 | 2014 |
| Prognostic Value of p27 in Follicular Thyroid Carcinoma and its Relation to Radioactive Iodine Response: Does it Aid in the Modification of Risk Stratification?. M Kotb, A Zaher, MA El-Wahab, IL Abulkheir, M Hussein, S Salem Applied Immunohistochemistry & Molecular Morphology 22 (7), 511–517, 2014 | 2 | 2014 |
| F18-FET PET in pediatric brain tumors: integrative analysis of image derived parameters and clinico-pathological data. MA Elahmadawy, M El-Ayadi, S Ahmed, A Refaat, MH Eltaoudy, E Maher, ... The Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official …, 2020 | 1 | 2020 |
| Prognostic Value of F-18 FDG PET/CT Volume-Based Metabolic Parameters in Patients with Cancer Esophagus. D Deif, H Moustafa, H Fathy, A Abougabal, M Elazab, MA Elahmadawy Egyptian J. Nucl. Med 20 (1), 2020 | 1 | 2020 |
| [18F] FDG PET/CT volumetric biomarkers for non-invasive prediction of HER2 expression in breast cancer patients MA Elahmadawy, H Abdelhamed, DHG El-Din, M Eltohamy, AMI Hassan, ... Asia Oceania Journal of Nuclear Medicine and Biology 13 (1), 10, 2025 | | 2025 |
| Nuclear Medicine Status in Egypt: Our Beginnings and Where We Are Now. H Mohamed Moustafa, M Elahmadawy Egyptian Journal Nuclear Medicine 29 (2), 1-10, 2024 | | 2024 |
| Potentials of pretreatment [18F] FDG PET/CT for non-invasive prediction of the tumor unfavorable pathological indices and microenvironment in NSCLC NM Fadl, H Moustafa, I Elantably, H Abdelazim, ME Sobeih, RM Allam, ... Clinical and Translational Imaging, 1-10, 2024 | | 2024 |
